169 related articles for article (PubMed ID: 30408591)
1. Portrait of blood-derived extracellular vesicles in patients with Parkinson's disease.
Lamontagne-Proulx J; St-Amour I; Labib R; Pilon J; Denis HL; Cloutier N; Roux-Dalvai F; Vincent AT; Mason SL; Williams-Gray C; Duchez AC; Droit A; Lacroix S; Dupré N; Langlois M; Chouinard S; Panisset M; Barker RA; Boilard E; Cicchetti F
Neurobiol Dis; 2019 Apr; 124():163-175. PubMed ID: 30408591
[TBL] [Abstract][Full Text] [Related]
2. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
Chung CC; Chan L; Chen JH; Hung YC; Hong CT
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived extracellular vesicles in Huntington's disease.
Denis HL; Lamontagne-Proulx J; St-Amour I; Mason SL; Weiss A; Chouinard S; Barker RA; Boilard E; Cicchetti F
J Neurol; 2018 Nov; 265(11):2704-2712. PubMed ID: 30209650
[TBL] [Abstract][Full Text] [Related]
4. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.
Chung CC; Chan L; Chen JH; Bamodu OA; Chiu HW; Hong CT
FASEB J; 2021 Oct; 35(10):e21895. PubMed ID: 34478572
[TBL] [Abstract][Full Text] [Related]
5. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease.
Wang S; Kojima K; Mobley JA; West AB
EBioMedicine; 2019 Jul; 45():351-361. PubMed ID: 31229437
[TBL] [Abstract][Full Text] [Related]
7. Cytokine Profile in Plasma Extracellular Vesicles of Parkinson's Disease and the Association with Cognitive Function.
Chan L; Chung CC; Chen JH; Yu RC; Hong CT
Cells; 2021 Mar; 10(3):. PubMed ID: 33803292
[TBL] [Abstract][Full Text] [Related]
8. Raman profiling of circulating extracellular vesicles for the stratification of Parkinson's patients.
Gualerzi A; Picciolini S; Carlomagno C; Terenzi F; Ramat S; Sorbi S; Bedoni M
Nanomedicine; 2019 Nov; 22():102097. PubMed ID: 31648040
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study.
Grossi I; Radeghieri A; Paolini L; Porrini V; Pilotto A; Padovani A; Marengoni A; Barbon A; Bellucci A; Pizzi M; Salvi A; De Petro G
Int J Mol Med; 2021 Feb; 47(2):533-546. PubMed ID: 33416118
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.
Lööv C; Scherzer CR; Hyman BT; Breakefield XO; Ingelsson M
Cell Mol Neurobiol; 2016 Apr; 36(3):437-48. PubMed ID: 26993503
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
Posavi M; Diaz-Ortiz M; Liu B; Swanson CR; Skrinak RT; Hernandez-Con P; Amado DA; Fullard M; Rick J; Siderowf A; Weintraub D; McCluskey L; Trojanowski JQ; Dewey RB; Huang X; Chen-Plotkin AS
PLoS Med; 2019 Oct; 16(10):e1002931. PubMed ID: 31603904
[TBL] [Abstract][Full Text] [Related]
12. Proteomics Profiling of Neuron-Derived Small Extracellular Vesicles from Human Plasma: Enabling Single-Subject Analysis.
Anastasi F; Masciandaro SM; Carratore RD; Dell'Anno MT; Signore G; Falleni A; McDonnell LA; Bongioanni P
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799461
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
[TBL] [Abstract][Full Text] [Related]
14. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
15. An Update on Peripheral Blood Extracellular Vesicles as Biomarkers for Parkinson's Disease Diagnosis.
Wang K; Shen J; Xu Y
Neuroscience; 2023 Feb; 511():131-146. PubMed ID: 36435476
[TBL] [Abstract][Full Text] [Related]
16. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
Wang X; Yu S; Li F; Feng T
Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
[TBL] [Abstract][Full Text] [Related]
17. Plasma extracellular vesicle synaptic proteins as biomarkers of clinical progression in patients with Parkinson's disease.
Hong CT; Chung CC; Yu RC; Chan L
Elife; 2024 Mar; 12():. PubMed ID: 38483306
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
[TBL] [Abstract][Full Text] [Related]
19. Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses.
Marcoux G; Duchez AC; Cloutier N; Provost P; Nigrovic PA; Boilard E
Sci Rep; 2016 Oct; 6():35928. PubMed ID: 27786276
[TBL] [Abstract][Full Text] [Related]
20. Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
Eidson LN; Kannarkat GT; Barnum CJ; Chang J; Chung J; Caspell-Garcia C; Taylor P; Mollenhauer B; Schlossmacher MG; Ereshefsky L; Yen M; Kopil C; Frasier M; Marek K; Hertzberg VS; Tansey MG
J Neuroinflammation; 2017 Aug; 14(1):164. PubMed ID: 28821274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
